文献速递心血管MR

微循环阻力指数用于表征微血管阻塞并预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的梗死面积回缩

Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI.
PubMed 文献 · JACC Cardiovasc Imaging · 2018-04-18

研究纳入110例接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者,术后即刻测微循环阻力指数(IMR),48小时和6个月用心脏磁共振量化梗死面积。IMR与微血管阻塞(MVO)不一致见于36.7%病例;同时存在MVO且IMR>40者6个月最终梗死面积>25%的风险增加11.9倍。

要点

  • IMR与MVO不一致见于36.7%病例,其中31例有MVO但IMR≤40。
  • 同时存在MVO且IMR>40者6个月最终梗死面积>25%的风险增加11.9倍(p=0.001)。
  • 有MVO且IMR≤40者6个月梗死面积显著更小,且随时间显著回缩。

核心结论

  • IMR与MVO在近三分之一病例中提供不一致的预后信息,但IMR有助于对MVO的程度和严重性进行分级。

研究设计与样本

  • 研究论文,共纳入110例接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者,术后即刻测量IMR,48小时(38.4±12.0小时)和6个月(194.0±20.0天)用心脏磁共振量化梗死面积(占左心室质量的百分比),48小时用心脏磁共振识别并量化MVO。

诊断标准与关键数值

  • IMR>40为原文采用的阈值,原文指出该阈值与不良临床结局相关。
  • 同时存在MVO且IMR>40者6个月最终梗死面积>25%的风险较有MVO且IMR≤40者增加11.9倍(p=0.001)。
  • 有MVO且IMR≤40者6个月梗死面积显著更小(p=0.001),梗死面积随时间显著回缩:34.4%(IQR 27.3%–41.0%)vs 22.3%(IQR 16.0%–30.0%),p=0.001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to compare the value of the index of microcirculatory resistance (IMR) and microvascular obstruction (MVO) measured by cardiac magnetic resonance (CMR) in patients treated for and recovering from ST-segment elevation myocardial infarction.

BACKGROUND: IMR can identify patients with microvascular dysfunction acutely after primary percutaneous coronary intervention (pPCI), and a threshold of >40 has been shown to be associated with an adverse clinical outcome. Similarly, MVO is recognized as an adverse feature in patients with ST-segment elevation myocardial infarction. Even though both IMR and MVO reflect coronary microvascular status, the interaction between these 2 parameters is uncertain.

METHODS: A total of 110 patients treated with pPCI were included, and IMR was measured immediately at completion of pPCI. Infarct size (IS) as a percentage of left ventricular mass was quantified at 48 h (38.4 ± 12.0 h) and 6 months (194.0 ± 20.0 days) using CMR. MVO was identified and quantified at 48 h by CMR.

RESULTS: Overall, a discordance between IMR and MVO was observed in 36.7% of cases, with 31 patients having MVO and IMR ≤40. Compared with patients with MVO and IMR ≤40, patients with both MVO and IMR >40 had an 11.9-fold increased risk of final IS >25% at 6 months (p = 0.001). Patients with MVO and IMR ≤40 had a significantly smaller IS at 6 months (p = 0.001), with significant regression in IS over time (34.4% [interquartile range (IQR): 27.3% to 41.0%] vs. 22.3% [IQR: 16.0% to 30.0%]; p = 0.001).

CONCLUSIONS: Discordant prognostic information was obtained from IMR and MVO in nearly one-third of cases; however, IMR can be helpful in grading the degree and severity of MVO.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. De Maria GL, Alkhalil M, Wolfrum M, et al. Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI. JACC Cardiovasc Imaging. 2018. PMID: 29680355. doi:10.1016/j.jcmg.2018.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。